C. S. Sutherland

发表

The canard project (projet canard) cost-effectiveness analysis of real-world outcomes in a diabetic population: The impact of baseline characteristics in France

Alan Brennan, C. S. Sutherland, M. Gillet, 2013 .

Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden

C. S. Sutherland, Z. Ademi, M. Ivarsson, 2020, PharmacoEconomics.

Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom

C. S. Sutherland, A. Lloyd, Yasmina Martí, 2021, PharmacoEconomics.

Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for Trypanosoma brucei gambiense.

C. S. Sutherland, M. Merritt, F. Tediosi, 2018, Public health ethics.

Human African trypanosomiasis prevention, treatment and control costs: a systematic review.

C. S. Sutherland, F. Tediosi, J. Keating, 2015, Acta tropica.

Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland

C. S. Sutherland, Z. Ademi, N. Schur, 2019, BMJ Open.

Seeing beyond 2020: an economic evaluation of contemporary and emerging strategies for elimination of Trypanosoma brucei gambiense.

C. S. Sutherland, M. Tanner, P. Steinmann, 2017, The Lancet. Global health.

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

C. S. Sutherland, Arjun Bhadhuri, M. Schwenkglenks, 2022, BMC Health Services Research.

Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management

C. S. Sutherland, N. Paracha, S. Mitchell, 2021, PharmacoEconomics.

A Literature Review of Economic Evaluations for a Neglected Tropical Disease: Human African Trypanosomiasis (“Sleeping Sickness”)

C. S. Sutherland, R. Goeree, F. Tediosi, 2015, PLoS neglected tropical diseases.

Preliminary characterization of a factor in human follicular fluid that stimulates human spermatozoa motion.

C. S. Sutherland, R. Casper, P. D. Josephy, 1994, Human reproduction.

Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa

C. S. Sutherland, F. Tediosi, 2019, BMJ Global Health.

Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review

Fabrizio Tediosi, Marcel Tanner, Peter Steinmann, 2015, Tropical medicine & international health : TM & IH.

Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)

C. S. Sutherland, N. Paracha, S. Mitchell, 2021, PharmacoEconomics.

Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn's disease using real world data.

C. S. Sutherland, C. Sokollik, J. Borovička, 2019, Journal of Crohn's & colitis.

Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers

C. S. Sutherland, N. Paracha, S. Mitchell, 2021, PharmacoEconomics.

A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives

C. S. Sutherland, Z. Ademi, M. Schwenkglenks, 2017, Journal of Thrombosis and Thrombolysis.